Arey, the Los Angeles-based beauty brand, has secured Series A funding led by Unilever Ventures, according to WWD Beauty. The company plans to deploy capital across research and development, retail expansion, and clinical validation studies.
The investment underscores Unilever's continued interest in acquiring emerging beauty brands with strong product-market fit and innovation potential. Unilever Ventures, the corporate venture arm of the consumer goods giant, has backed dozens of beauty startups over the past five years, including Prose, Madison Reed, and Billie. The firm typically invests in brands addressing specific consumer pain points with defensible formulations or business models.
Arey's backing from Unilever Ventures signals investor confidence in the brand's positioning and scalability. The company operates in a crowded market, but securing this level of institutional backing provides resources most indie beauty brands lack. R&D expansion matters in this space. Brands that can substantiate claims through clinical research attract retail buyers and justify premium pricing. Sephora, Ulta, and major department stores increasingly demand efficacy data before allocating shelf space to new brands. Arey's clinical research budget will strengthen its credibility with both retailers and consumers skeptical of marketing claims.
Retail partnerships represent the next growth phase for digitally native brands. Building direct-to-consumer channels through Instagram and owned websites generates higher margins, but wholesale distribution drives volume and brand awareness. Major retailers control category placement, consumer discovery, and repeat purchase behavior. The funding enables Arey to negotiate placement agreements and support in-store merchandising, critical for converting shelf browsers into buyers.
The investment also reflects a broader trend in venture funding. Beauty startups raised $1.2 billion in 2023, down from $1.8 billion in 2022, according to PitchBook data. Funding has become more selective, favoring brands with proven unit economics and clear paths to profitability. Generalist VCs have exited the space. Unilever Ventures, by contrast, brings strategic value beyond capital. The firm offers access to Unilever's supply chain, manufacturing expertise, and retail relationships spanning 190 countries. These assets matter more than pure funding in today's market.
The Los Angeles beauty ecosystem benefits from this deal. The city hosts emerging brands like Glow Recipe, Innerspeace, and Youth to the People, many backed by early-stage investors or bootstrapped founders. Venture interest in LA beauty validates the region's creative talent and manufacturing capabilities, distinct from New York's fragrance hub or other regional concentrations.
Arey's funding round also reflects consumer demand for personalization and efficacy-driven skincare. The brand likely addresses a specific category, whether targeted acne treatment, barrier repair, or anti-aging innovation. Consumers increasingly reject one-size-fits-all formulations and demand proof. Brands that combine smart positioning, clean ingredient transparency, and clinical validation command premium pricing and customer loyalty.
The next phase requires execution. Arey must convert R&D investments into retail-ready products that differentiate in category. Retail partnerships mean nothing without compelling consumer demand. Clinical studies take 12-24 months to complete, meaning visibility on product claims remains limited in the near term. The funding provides runway, but Unilever Ventures will expect measurable progress on distribution, revenue, and brand awareness within 18-24 months.